Upstream Bio Inc. (UPB)
NASDAQ: UPB
· Real-Time Price · USD
18.82
0.20 (1.07%)
At close: Aug 15, 2025, 3:14 PM
1.07% (1D)
| Bid | 18.79 |
| Market Cap | 1.01B |
| Revenue (ttm) | 2.3M |
| Net Income (ttm) | -79.18M |
| EPS (ttm) | -6.18 |
| PE Ratio (ttm) | -3.05 |
| Forward PE | -5.47 |
| Analyst | Buy |
| Ask | 18.89 |
| Volume | 312,630 |
| Avg. Volume (20D) | 469,685 |
| Open | 18.68 |
| Previous Close | 18.62 |
| Day's Range | 18.15 - 19.27 |
| 52-Week Range | 5.14 - 29.46 |
| Beta | 1.64 |
Analyst Forecast
According to 0 analyst ratings, the average rating for UPB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Upstream Bio Inc. is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
+7.83%
Upstream Bio shares are trading lower after the co...
Unlock content with
Pro Subscription
9 months ago
+8.91%
Upstream shares are trading higher after multiple firms initiated coverage on the stock with an Overweight rating.
